MediWound (MDWD) Tops Q4 EPS by 5c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
MediWound Reports Fourth Quarter and Full-Year 2020 Financial Results
February 25, 2021 7:01 AM ESTFourth Quarter Revenues of $6.7 Million - Up 23%
and Full-Year 2020 Revenues of $21.8 Million - Product Revenue Up 117%
Conference call begins today at 8:30 am ET
YAVNE, Israel, Feb. 25, 2021 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company focused on next-generation bio-therapeutic solutions for tissue repair and regeneration, today announced financial results for the fourth quarter and full-year ended December 31, 2020.
Fourth Quarter and Full-Year 2020 Financial... More



